Trials / Sponsors / Fundamenta Therapeutics, Ltd.
Fundamenta Therapeutics, Ltd.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Safety and Efficacy of ThisCART19A Bridging Hematopoietic Stem Cell Transplantation in Patients With Refractor Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited | Phase 1 | 2022-10-15 |
| Unknown | Safety and Clinical Activity of ThisCART19 in Patients With r/r Non-Hodgkin's B Cell Lymphoma B-cell Malignancy | Phase 1 | 2021-10-25 |
| Unknown | Safety and Clinical Activity of ThisCART22 in Patients With r/r Non-Hodgkin's B Cell Lymphoma B-cell Malignancy | Phase 1 | 2021-10-25 |
| Unknown | Safety and Efficacy of ThisCART22 in Patients With Refractory or Relapsed B Cell Malignancies B Cell Malignancy | Phase 1 | 2020-10-23 |
| Unknown | Safety and Efficacy of ThisCART19 in Patients With Refractory or Relapsed B Cell Malignancies B Cell Malignancy | Phase 1 | 2020-05-09 |
| Unknown | Safety and Efficacy of ThisCART7 in Patients With Refractory or Relapsed T Cell Malignancies T-Acute Lymphoblastic Leukemia, T-cell Non-Hodgkin Lymphoma, T-cell Acute Lymphoblastic Lymphoma | Phase 1 | 2020-01-22 |